history of tirzepatide What is the and development background Mounjaro? What Is Tirzepatide? How It

Taking Mounjaro requires careful monitoring for GLP-1 overexposure which may cause pancreatitis (inflammation of the pancreas), especially following a bariatric (weight loss) surgery

A systematic review found that GLP-1 receptor agonists significantly reduced albuminuria, a marker of kidney damage, and slowed the decline in kidney function, particularly in patients with early-stage renal disease

Vomiting (coded as R11.1 for vomiting alone, plus Y42.3) occurs in 812% of patients and may necessitate temporary dose reduction or treatment interruption if severe

The following are documented in published clinical data and are not edge cases